VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $73,000 | – | 15,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,896,902 | $4,173,000 | 5.19% |
| Knoll Capital Management, LLC | 896,771 | $1,973,000 | 1.68% |
| SABBY MANAGEMENT, LLC | 1,856,169 | $4,084,000 | 0.63% |
| 683 Capital Management, LLC | 346,574 | $762,000 | 0.05% |
| Virtu Financial LLC | 64,203 | $141,000 | 0.01% |
| Spark Investment Management LLC | 29,300 | $64,000 | 0.00% |
| Alyeska Investment Group, L.P. | 83,333 | $183,000 | 0.00% |
| Burt Wealth Advisors | 1,674 | $4,000 | 0.00% |
| A.R.T. Advisors, LLC | 24,682 | $54,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 29,220 | $64,000 | 0.00% |